LONDON (Reuters) - AstraZeneca's sales slumped by a bigger-than-expected 19 percent in the third quarter, underscoring the challenges confronting the drugmaker's new chief executive, Pascal Soriot. Faced with patent expiries on once best-selling medicines and a thin pipeline of new drugs, the former Roche executive, who joined on October 1, needs to re-focus operations and step up the hunt for acquisitions, analysts believe. ...
via Health News Headlines - Yahoo! News Read More Here..
For a Free Step By Step Guide for Dating Dos and Don'ts check http://end2endwebs.com
No comments:
Post a Comment